The United States Patent and Trademark Office (USPTO) has recently launched two new initiatives to support COVID-19 innovations: 1) a COVID-19 Prioritized Examination Pilot Program, and 2) Patents 4 Partnerships that provides...more
5/15/2020
/ Artificial Intelligence ,
Coronavirus/COVID-19 ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Patent Applications ,
Patent Examinations ,
Patents ,
Prioritized Examination ,
Request for Continued Examination ,
USPTO ,
USPTO Pilot Program